rs781059624
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000382.3(ALDH3A2):c.1291_1292delAA(p.Lys431GlufsTer5) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000382.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461890Hom.: 0 AF XY: 0.00000413 AC XY: 3AN XY: 727246
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Sjögren-Larsson syndrome Pathogenic:4
The proband has another variant, NM_000382.2: c.1309A>T (p.Lys437*). -
- -
Variant summary: The ALDH3A2 c.1291_1292delAA (p.Lys431Glufs) variant results in a premature termination codon, predicted to cause a truncated or absent ALDH3A2 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. One in silico tool predicts a damaging outcome for this variant. This variant was found in 1/121534 control chromosomes at a frequency of 0.0000082, which does not exceed the estimated maximal expected allele frequency of a pathogenic ALDH3A2 variant (0.0017889). This variant has been reported in multiple SLS pts as homozygote or compound heterozygotes. Taken together, this variant is classified as pathogenic. -
The p.Lys431GlufsX5 variant in ALDH3A2 has been reported in the homozygous or co mpound heterozygous state in 2 Japanese individuals with Sjogren-Larsson syndrom e and segregated with disease in 1 affected family member (Rizzo 1999, Takeichi 2013 ). It has also been identified in 1/17248 of East Asian chromosomes by gnom AD (http://gnomad.broadinstitute.org). This variant has also been reported in Cl inVar (Variation ID 495850). This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 431 and leads to a premature termination codon 5 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the ALDH3A2 gene is an established disease mechanism in Sjogren-Larsson syndrome. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Sjogren-Larsson syndrome based on case observations, segregation studies, and predicted impact on protein. ACMG/AMP Criteria applied: PVS1, PM2, PM 3, PP1. -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Lys431Glufs*5) in the ALDH3A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALDH3A2 are known to be pathogenic (PMID: 10577908, 10854114). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 495850). This premature translational stop signal has been observed in individual(s) with Sjogren-Larsson syndrome (PMID: 10577908, 30157790). This variant is present in population databases (rs781059624, gnomAD 0.006%). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at